Change in QOL and symptom severity scores according to presence or absence of atrial fibrillation recurrence >30 s
. | All . | P-valuea . | Recurrent . | P-valuea . | Non-recurrent . | P-valuea . | P-valueb . |
---|---|---|---|---|---|---|---|
AFEQT | (n) Mean ± SD | (n) Mean ± SD | (n) Mean ± SD | ||||
Baseline | (225) 55.28 ± 22.78 | <0.001 | (120) 51.91 ± 22.35 | <0.001 | (93) 59.44 ± 22.76 | <0.001 | |
12-month | (192) 82.93 ± 19.53 | (110) 75.41 ± 21.75 | (82) 92.73 ± 9.76 | ||||
Δ (12 month-Baseline) | (189) 27.77 ± 24.13 | (107) 23.68 ± 24.99 | (82) 33.09 ± 21.99 | 0.008 | |||
PCS | |||||||
Baseline | (220) 43.03 ± 11.82 | <0.001 | (116) 42.83 ± 12.27 | <0.001 | (92) 43.54 ± 11.27 | <0.001 | |
12-month | (192) 49.34 ± 10.16 | (110) 46.93 ± 11.30 | (82) 52.58 ± 7.29 | ||||
Δ (12 month-Baseline) | (185) 6.19 ± 11.00 | (104) 4.09 ± 11.13 | (81) 8.89 ± 10.30 | 0.003 | |||
MCS | |||||||
Baseline | (220) 43.67 ± 12.94 | <0.001 | (116) 42.34 ± 13.34 | <0.001 | (92) 45.21 ± 12.64 | <0.001 | |
12-month | (192) 50.24 ± 11.58 | (110) 48.20 ± 12.20 | (82) 52.98 ± 10.15 | ||||
Δ (12 month-Baseline) | (185) 6.78 ± 13.74 | (104) 5.79 ± 15.25 | (81) 8.05 ± 11.47 | 0.26 | |||
CCS-SAF | |||||||
Baseline | (226) 2.30 ± 1.13 | <0.001 | (123) 2.35 ± 1.14 | <0.001 | (91) 2.22 ± 1.12 | <0.001 | |
12-month | (196) 0.67 ± 1.10 | (114) 1.11 ± 1.24 | (82) 0.06 ± 0.36 | ||||
Δ (12 month-Baseline) | (194) −1.60 ± 1.48 | (113) −1.23 ± 1.59 | (81) −2.10 ± 1.12 | <0.001 |
. | All . | P-valuea . | Recurrent . | P-valuea . | Non-recurrent . | P-valuea . | P-valueb . |
---|---|---|---|---|---|---|---|
AFEQT | (n) Mean ± SD | (n) Mean ± SD | (n) Mean ± SD | ||||
Baseline | (225) 55.28 ± 22.78 | <0.001 | (120) 51.91 ± 22.35 | <0.001 | (93) 59.44 ± 22.76 | <0.001 | |
12-month | (192) 82.93 ± 19.53 | (110) 75.41 ± 21.75 | (82) 92.73 ± 9.76 | ||||
Δ (12 month-Baseline) | (189) 27.77 ± 24.13 | (107) 23.68 ± 24.99 | (82) 33.09 ± 21.99 | 0.008 | |||
PCS | |||||||
Baseline | (220) 43.03 ± 11.82 | <0.001 | (116) 42.83 ± 12.27 | <0.001 | (92) 43.54 ± 11.27 | <0.001 | |
12-month | (192) 49.34 ± 10.16 | (110) 46.93 ± 11.30 | (82) 52.58 ± 7.29 | ||||
Δ (12 month-Baseline) | (185) 6.19 ± 11.00 | (104) 4.09 ± 11.13 | (81) 8.89 ± 10.30 | 0.003 | |||
MCS | |||||||
Baseline | (220) 43.67 ± 12.94 | <0.001 | (116) 42.34 ± 13.34 | <0.001 | (92) 45.21 ± 12.64 | <0.001 | |
12-month | (192) 50.24 ± 11.58 | (110) 48.20 ± 12.20 | (82) 52.98 ± 10.15 | ||||
Δ (12 month-Baseline) | (185) 6.78 ± 13.74 | (104) 5.79 ± 15.25 | (81) 8.05 ± 11.47 | 0.26 | |||
CCS-SAF | |||||||
Baseline | (226) 2.30 ± 1.13 | <0.001 | (123) 2.35 ± 1.14 | <0.001 | (91) 2.22 ± 1.12 | <0.001 | |
12-month | (196) 0.67 ± 1.10 | (114) 1.11 ± 1.24 | (82) 0.06 ± 0.36 | ||||
Δ (12 month-Baseline) | (194) −1.60 ± 1.48 | (113) −1.23 ± 1.59 | (81) −2.10 ± 1.12 | <0.001 |
AFEQT, Atrial Fibrillation Effect on QualiTy-of-life; CCS_SAF, Canadian Cardiovascular Society Severity in Atrial Fibrillation; MCS, mental component score; PCS, physical component score.
P-value of difference between baseline and 12-months.
P-value of difference between recurrent and non-recurrent.
Δ (12 month-baseline): change in AFB at 12 months vs. baseline.
Change in QOL and symptom severity scores according to presence or absence of atrial fibrillation recurrence >30 s
. | All . | P-valuea . | Recurrent . | P-valuea . | Non-recurrent . | P-valuea . | P-valueb . |
---|---|---|---|---|---|---|---|
AFEQT | (n) Mean ± SD | (n) Mean ± SD | (n) Mean ± SD | ||||
Baseline | (225) 55.28 ± 22.78 | <0.001 | (120) 51.91 ± 22.35 | <0.001 | (93) 59.44 ± 22.76 | <0.001 | |
12-month | (192) 82.93 ± 19.53 | (110) 75.41 ± 21.75 | (82) 92.73 ± 9.76 | ||||
Δ (12 month-Baseline) | (189) 27.77 ± 24.13 | (107) 23.68 ± 24.99 | (82) 33.09 ± 21.99 | 0.008 | |||
PCS | |||||||
Baseline | (220) 43.03 ± 11.82 | <0.001 | (116) 42.83 ± 12.27 | <0.001 | (92) 43.54 ± 11.27 | <0.001 | |
12-month | (192) 49.34 ± 10.16 | (110) 46.93 ± 11.30 | (82) 52.58 ± 7.29 | ||||
Δ (12 month-Baseline) | (185) 6.19 ± 11.00 | (104) 4.09 ± 11.13 | (81) 8.89 ± 10.30 | 0.003 | |||
MCS | |||||||
Baseline | (220) 43.67 ± 12.94 | <0.001 | (116) 42.34 ± 13.34 | <0.001 | (92) 45.21 ± 12.64 | <0.001 | |
12-month | (192) 50.24 ± 11.58 | (110) 48.20 ± 12.20 | (82) 52.98 ± 10.15 | ||||
Δ (12 month-Baseline) | (185) 6.78 ± 13.74 | (104) 5.79 ± 15.25 | (81) 8.05 ± 11.47 | 0.26 | |||
CCS-SAF | |||||||
Baseline | (226) 2.30 ± 1.13 | <0.001 | (123) 2.35 ± 1.14 | <0.001 | (91) 2.22 ± 1.12 | <0.001 | |
12-month | (196) 0.67 ± 1.10 | (114) 1.11 ± 1.24 | (82) 0.06 ± 0.36 | ||||
Δ (12 month-Baseline) | (194) −1.60 ± 1.48 | (113) −1.23 ± 1.59 | (81) −2.10 ± 1.12 | <0.001 |
. | All . | P-valuea . | Recurrent . | P-valuea . | Non-recurrent . | P-valuea . | P-valueb . |
---|---|---|---|---|---|---|---|
AFEQT | (n) Mean ± SD | (n) Mean ± SD | (n) Mean ± SD | ||||
Baseline | (225) 55.28 ± 22.78 | <0.001 | (120) 51.91 ± 22.35 | <0.001 | (93) 59.44 ± 22.76 | <0.001 | |
12-month | (192) 82.93 ± 19.53 | (110) 75.41 ± 21.75 | (82) 92.73 ± 9.76 | ||||
Δ (12 month-Baseline) | (189) 27.77 ± 24.13 | (107) 23.68 ± 24.99 | (82) 33.09 ± 21.99 | 0.008 | |||
PCS | |||||||
Baseline | (220) 43.03 ± 11.82 | <0.001 | (116) 42.83 ± 12.27 | <0.001 | (92) 43.54 ± 11.27 | <0.001 | |
12-month | (192) 49.34 ± 10.16 | (110) 46.93 ± 11.30 | (82) 52.58 ± 7.29 | ||||
Δ (12 month-Baseline) | (185) 6.19 ± 11.00 | (104) 4.09 ± 11.13 | (81) 8.89 ± 10.30 | 0.003 | |||
MCS | |||||||
Baseline | (220) 43.67 ± 12.94 | <0.001 | (116) 42.34 ± 13.34 | <0.001 | (92) 45.21 ± 12.64 | <0.001 | |
12-month | (192) 50.24 ± 11.58 | (110) 48.20 ± 12.20 | (82) 52.98 ± 10.15 | ||||
Δ (12 month-Baseline) | (185) 6.78 ± 13.74 | (104) 5.79 ± 15.25 | (81) 8.05 ± 11.47 | 0.26 | |||
CCS-SAF | |||||||
Baseline | (226) 2.30 ± 1.13 | <0.001 | (123) 2.35 ± 1.14 | <0.001 | (91) 2.22 ± 1.12 | <0.001 | |
12-month | (196) 0.67 ± 1.10 | (114) 1.11 ± 1.24 | (82) 0.06 ± 0.36 | ||||
Δ (12 month-Baseline) | (194) −1.60 ± 1.48 | (113) −1.23 ± 1.59 | (81) −2.10 ± 1.12 | <0.001 |
AFEQT, Atrial Fibrillation Effect on QualiTy-of-life; CCS_SAF, Canadian Cardiovascular Society Severity in Atrial Fibrillation; MCS, mental component score; PCS, physical component score.
P-value of difference between baseline and 12-months.
P-value of difference between recurrent and non-recurrent.
Δ (12 month-baseline): change in AFB at 12 months vs. baseline.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.